Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Jennifer K, Burzawa"'
Autor:
Talayeh S. Ghezelayagh, Brendan F. Kohrn, Jeanne Fredrickson, Enna Manhardt, Marc R. Radke, Ronit Katz, Heidi J. Gray, Renata R. Urban, Kathryn P. Pennington, John B. Liao, Kemi M. Doll, Elise J. Simons, Jennifer K. Burzawa, Barbara A. Goff, Paul Speiser, Elizabeth M. Swisher, Barbara M. Norquist, Rosa Ana Risques
Publikováno v:
Cancer Research Communications. 2:1282-1292
Current screening methods for ovarian cancer have failed to demonstrate a significant reduction in mortality. Uterine lavage combined with TP53 ultradeep sequencing for the detection of disseminated ovarian cancer cells has emerged as a promising too
Autor:
Talayeh S, Ghezelayagh, Brendan F, Kohrn, Jeanne, Fredrickson, Enna, Manhardt, Marc R, Radke, Ronit, Katz, Heidi J, Gray, Renata R, Urban, Kathryn P, Pennington, John B, Liao, Kemi M, Doll, Elise J, Simons, Jennifer K, Burzawa, Barbara A, Goff, Paul, Speiser, Elizabeth M, Swisher, Barbara M, Norquist, Rosa Ana, Risques
Publikováno v:
Cancer Res Commun
Current screening methods for ovarian cancer (OC) have failed to demonstrate a significant reduction in mortality. Uterine lavage combined with TP53 ultra-deep sequencing for the detection of disseminated OC cells has emerged as a promising tool, but
Autor:
Rosa Ana Risques, Barbara M. Norquist, Elizabeth M. Swisher, Paul Speiser, Barbara A. Goff, Jennifer K. Burzawa, Elise J. Simons, Kemi M. Doll, John B. Liao, Kathryn P. Pennington, Renata R. Urban, Heidi J. Gray, Ronit Katz, Marc R. Radke, Enna Manhardt, Jeanne Fredrickson, Brendan F. Kohrn, Talayeh S. Ghezelayagh
Current screening methods for ovarian cancer have failed to demonstrate a significant reduction in mortality. Uterine lavage combined with TP53 ultradeep sequencing for the detection of disseminated ovarian cancer cells has emerged as a promising too
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935b8042855ea29e7c605d33eb84f855
https://doi.org/10.1158/2767-9764.c.6550803
https://doi.org/10.1158/2767-9764.c.6550803
Autor:
Rosa Ana Risques, Barbara M. Norquist, Elizabeth M. Swisher, Paul Speiser, Barbara A. Goff, Jennifer K. Burzawa, Elise J. Simons, Kemi M. Doll, John B. Liao, Kathryn P. Pennington, Renata R. Urban, Heidi J. Gray, Ronit Katz, Marc R. Radke, Enna Manhardt, Jeanne Fredrickson, Brendan F. Kohrn, Talayeh S. Ghezelayagh
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::779d5debab4067df26859628fcf93f10
https://doi.org/10.1158/2767-9764.22544940
https://doi.org/10.1158/2767-9764.22544940
Autor:
Rosa Ana Risques, Barbara M. Norquist, Elizabeth M. Swisher, Paul Speiser, Barbara A. Goff, Jennifer K. Burzawa, Elise J. Simons, Kemi M. Doll, John B. Liao, Kathryn P. Pennington, Renata R. Urban, Heidi J. Gray, Ronit Katz, Marc R. Radke, Enna Manhardt, Jeanne Fredrickson, Brendan F. Kohrn, Talayeh S. Ghezelayagh
Table S1. Clinical patient informationTable S2. Duplex Sequencing gene targetsTable S3. Custom probes for hotspotsTable S4. Mutation Frequency and Mutation Burden by patient and geneTable S5. Codons most frequently mutated in ovarian cancersTable S6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74307ae151fd8adb045ea362a8686575
https://doi.org/10.1158/2767-9764.22544937
https://doi.org/10.1158/2767-9764.22544937
Autor:
Rosa Ana Risques, Barbara M. Norquist, Elizabeth M. Swisher, Paul Speiser, Barbara A. Goff, Jennifer K. Burzawa, Elise J. Simons, Kemi M. Doll, John B. Liao, Kathryn P. Pennington, Renata R. Urban, Heidi J. Gray, Ronit Katz, Marc R. Radke, Enna Manhardt, Jeanne Fredrickson, Brendan F. Kohrn, Talayeh S. Ghezelayagh
S1. Experimental designS2. Association between the variant allele frequency (VAF) of tumor mutations identified in uterine lavage with stage of the ovarian cancer (A) and preoperative CA-125 level (B)S3. Gene distribution of the largest mutant clones
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846abd237654468ab3ecaaf6e86d4136
https://doi.org/10.1158/2767-9764.22544943
https://doi.org/10.1158/2767-9764.22544943
Autor:
Lauren Averett Byers, Mark F. Munsell, Michael Frumovitz, Jennifer K. Burzawa, Robert L. Coleman, Preetha Ramalingam, Jennifer R. Brown
Publikováno v:
Gynecologic Oncology. 144:46-50
To assess if the combination of topotecan, paclitaxel, and bevacizumab (TPB) was active in recurrent SCCC and to compare the survival of patients with SCCC who received TPB to a group of women with SCCC who did not receive this regimen.We retrospecti
Autor:
Preetha Ramalingam, Shane R. Stecklein, Ann H. Klopp, Michael Frumovitz, Patricia J. Eifel, Anuja Jhingran, Jennifer K. Burzawa
Publikováno v:
Gynecologic Oncology. 143:552-557
Objective To analyze patterns of recurrence and survival and identify prognostic factors in women with neuroendocrine cervical cancer (NECC). Methods We reviewed patients with International Federation of Gynecology and Obstetrics stage I–IVA NECC w
Autor:
Diana L. Urbauer, Charlotte C. Sun, Pamela T. Soliman, J.B. Pakish, Karen H. Lu, Frances A. Smith, Anthony J. Greisinger, Bryan Fellman, Jennifer K. Burzawa
Publikováno v:
Journal of Women's Health. 25:1187-1192
The majority of women with endometrial cancer (EC) present at an early stage with an associated 5-year survival rate of90%. High rates of early detection are attributed to warning symptoms; however, the prevalence of such symptoms has not been well d
Autor:
Kathleen M. Schmeler, Deepthi James, Linda Graviss, Thomas A. Aloia, Keith N. Myers, Shital Vachhani, K. Potts, Claire A. Marten, Charles F Levenback, Diane C. Bodurka, Larissa A. Meyer, Jolyn S. Taylor, Lynn M. Cloutier, Cheryl Hubbs, Anne K. Park, Alpa M. Nick, Tara N. Tatum, Katherine E. Cain, Shauna Fenton, Kathy M. Ware, Jennifer K. Burzawa
Publikováno v:
Journal of Oncology Practice. 12:e878-e883
Purpose: Surgical site infections (SSIs) are associated with patient morbidity and increased health care costs. Although several national organizations including the University HealthSystem Consortium (UHC), the National Surgical Quality Improvement